Single Institution Experience With Neoadjuvant Treatment of Borderline Resectable Pancreatic Adenocarcinoma: Achieving R0 Resection With Modern Chemotherapy

被引：0
|
作者：
Bolton, Nathan
Conway, William C.
Bolton, John S.
机构：
来源：
GASTROENTEROLOGY | 2014年 / 146卷 / 05期
关键词：
D O I：
暂无
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
515
引用
收藏
页码：S1018 / S1018
页数：1
相关论文
共 50 条
  • [1] Neoadjuvant treatment for borderline resectable pancreatic adenocarcinoma is associated with higher R0 rate compared to upfront surgery
    Terlizzi, Mario
    Buscail, Etienne
    Boussari, Olayide
    Adgie, Sarah
    Leduc, Nicolas
    Terrebonne, Eric
    Smith, Denis
    Blanc, Jean-Frederic
    Lapuyade, Bruno
    Laurent, Christophe
    Chiche, Laurence
    Belleannee, Genevieve
    Le Malicot, Karine
    Trouette, Renaud
    Pouypoudat, Claudia
    Vendrely, Veronique
    ACTA ONCOLOGICA, 2021, 60 (09) : 1114 - 1121
  • [2] Neoadjuvant Therapy for Achieving Margin Negative Resection in Borderline Resectable Pancreatic Ductal Adenocarcinoma
    Chandrasekaran, S.
    Coveler, A. L.
    Chandrasekaran, S.
    Lucas, F. R.
    Patel, S.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2013, 87 (02): : S314 - S314
  • [3] SBRT with Simultaneous Integrated Boost Results in High Rate of R0 Resection in Borderline Resectable Pancreatic Adenocarcinoma
    Ennis, W. H.
    Chaudhari, R.
    Daugherty, E. C.
    Tanny, S.
    Jain, A.
    Jurdi, A.
    Banashkevich, A. V.
    Bogart, V. J. A.
    Shapiro, A.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2018, 102 (03): : E72 - E72
  • [4] Neoadjuvant Gemcitabine Chemotherapy followed by Concurrent IMRT Simultaneous Boost Achieves High R0 Resection in Borderline Resectable Pancreatic Cancer Patients
    Huang, Xiaolun
    Knoble, Jeanna L.
    Zeng, Ming
    Aguila, Fernando N.
    Patel, Tara
    Chambers, Lowell W.
    Hu, Honglin
    Liu, Hao
    PLOS ONE, 2016, 11 (12):
  • [5] Impact of neoadjuvant chemotherapy and stereotactic body radiation therapy (SBRT) on R0 resection rate for borderline resectable and locally advanced pancreatic cancer
    Zakem, Sara J.
    Mueller, Adam C.
    Meguid, Cheryl
    Torphy, Robert J.
    Holt, Douglas E.
    Schefter, Tracey
    Messersmith, Wells A.
    McCarter, Martin D.
    Del Chiaro, Marco
    Schulick, Richard D.
    Goodman, Karyn A.
    HPB, 2021, 23 (07) : 1072 - 1083
  • [6] Prognostic factors for achieving resection following neoadjuvant radiation therapy for borderline resectable pancreatic adenocarcinoma
    Dholakia, Avani Satish
    Hacker-Prietz, Amy
    Wild, Aaron Tyler
    Raman, Siva P.
    Wood, Laura D.
    Laheru, Daniel A.
    Zheng, Lei
    De Jesus-Acosta, Ana
    Dung Thi Le
    Rasheed, Zeshaan
    Ellsworth, Susannah G.
    Kumar, Rachit
    Fan, Katherine Y.
    Pawlik, Timothy M.
    Makary, Martin
    Hruban, Ralph H.
    Cameron, John L.
    Fishman, Elliott K.
    Wolfgang, Christopher Lee
    Herman, Joseph M.
    JOURNAL OF CLINICAL ONCOLOGY, 2013, 31 (04)
  • [7] Outcomes of neoadjuvant chemotherapy with FOLFOX/FOLFIRINOX and chemoradiotherapy in borderline resectable pancreatic cancer: Single-institution experience
    Son, Chang O.
    Pai, Sachin Gopalkrishn
    Satti, Suma
    Dornelles, Adriana
    Bolton, John S.
    Conway, W. Charles
    Fuloria, Jyotsna
    JOURNAL OF CLINICAL ONCOLOGY, 2014, 32 (03)
  • [8] Neoadjuvant treatment for borderline and resectable pancreatic ductal adenocarcinoma
    R. Álvarez
    I. Alés
    R. Díaz
    B. G. de Paredes
    M. Hidalgo
    Clinical and Translational Oncology, 2017, 19 : 1193 - 1198
  • [9] Neoadjuvant Treatment for Borderline Resectable Pancreatic Ductal Adenocarcinoma
    Kaufmann, Benedikt
    Hartmann, Daniel
    D'Haese, Jan G.
    Stupakov, Pavel
    Radenkovic, Dejan
    Gloor, Beat
    Friess, Helmut
    DIGESTIVE SURGERY, 2019, 36 (06) : 455 - 461
  • [10] Efficacy of Neoadjuvant Chemotherapy and Radiation in Resectable/Borderline Resectable Pancreatic Ductal Adenocarcinoma
    Kelley, Jesse K.
    Kolbeinsson, Hordur
    Eastburg, Benjamin
    Frisch, Austin
    Khan, Mariam
    Wright, Gerald P.
    Assifi, Mura
    Chandra, Sreenivasa
    Chung, Mathew
    ANNALS OF SURGICAL ONCOLOGY, 2023, 30 (SUPPL 1) : S176 - S177
12345